Another Headline

Large molecule drug discovery begins with identifying the functional therapeutic target and evaluating its role in the disease of interest. This identification is then followed by characterization of the molecular mechanisms addressed by this target. All targets should be druggable and modulated by the potential therapeutic.

These early phases have been simplified by the advent of various genome engineering and hybridoma techniques, which can be used for biotherapeutic antibody target and lead discovery.

Problem Statement

Uncover, select, and validate new targets with a strong link to disease. Choices made early in the drug discovery process are highly linked to ultimate failure or success in a drug discovery program. Identification of the most suitable, druggable target is key to success. We offer a complete set of curated genome-wide, pathway-specific, and protein family targeting screening tools to facilitate your target discovery